Article Details

Magenta Therapeutics Secures $52M in Series C Financing

Retrieved on: 2018-04-09 05:45:00

Tags for this article:

Click the tags to see associated articles and topics

Magenta Therapeutics Secures $52M in Series C Financing. View article details on hiswai:

Excerpt

<div>Launched in 2016 by Third Rock Ventures and <b>Atlas Venture</b> and led by Jason Gardner, D.Phil., chief executive officer, president and co-founder, Magenta Therapeutics is a biotechnology company developing therapeutics for bone marrow transplant for patients with autoimmune diseases, blood ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up